Therapeutic outcome of quercetin nanoparticles on Cerastes cerastes venom-induced hepatorenal toxicity: a preclinical study

Nanomedicine (Lond). 2023 Feb;18(4):367-390. doi: 10.2217/nnm-2022-0188. Epub 2023 Apr 26.

Abstract

Aim: The objective of this study was to investigate the therapeutic potential of quercetin (QT) and QT-loaded poly(lactic-co-glycolic acid) nanoparticles (QT-NPs) on Cerastes cerastes venom-mediated inflammation, redox imbalance, hepatorenal tissue damage and local hemorrhage. Methods: The developed QT-NPs were first submitted to physicochemical characterization and then evaluated in the 'challenge then treat' and 'preincubation' models of envenoming. Results: QT-NPs efficiently alleviated hepatorenal toxicity, inflammation and redox imbalance and significantly attenuated venom-induced local hemorrhage. Interestingly, QT-NPs were significantly more efficient than free QT at 24 h postenvenoming, pointing to the efficacy of this drug-delivery system. Conclusion: These findings highlight the therapeutic potential of QT-NPs on venom-induced toxicity and open up the avenue for their use in the management of snakebite envenoming.

Keywords: Cerastes cerastes venom; hepatotoxicity; inflammation; nanomedicine; oxidative stress; quercetin–PLGA nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hemorrhage / chemically induced
  • Inflammation / chemically induced
  • Nanoparticles* / chemistry
  • Nanoparticles* / toxicity
  • Quercetin / pharmacology
  • Quercetin / therapeutic use
  • Treatment Outcome
  • Viper Venoms / adverse effects
  • Viper Venoms / chemistry
  • Viperidae*

Substances

  • Quercetin
  • Viper Venoms